Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityNo recent work listed

Ying Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6594-1579; OpenAlex author ID A5100383077. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. FERMT1 Is a Prognostic Marker Involved in Immune Infiltration of Pancreatic Adenocarcinoma Correlating with m6A Modification and Necroptosis. Last author DOI 10.3390/genes14030734↗
  2. NEAT1 regulates pancreatic cancer cell growth, invasion and migration though mircroRNA-335-5p/c-met axis. Co-author PMID 27822425↗
  3. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/or.2013.2420↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qian Wu · 1 shared paper, 2023 · strength 0.18
  2. Jia-Chun Yang · 1 shared paper, 2016 · strength 0.06
  3. Yi Zhang · 1 shared paper, 2016 · strength 0.06
  4. Jia Cao · 1 shared paper, 2016 · strength 0.06
  5. Leiming Xu · 1 shared paper, 2016 · strength 0.06
  6. Ming-hua Zhu · 1 shared paper, 2013 · strength 0.04
  7. Jing Zhang · 1 shared paper, 2013 · strength 0.04
  8. Qinghua Liu · 1 shared paper, 2013 · strength 0.04
  9. Chenyan Zhao · 1 shared paper, 2013 · strength 0.04
  10. Min Shi · 1 shared paper, 2013 · strength 0.04
  11. Shu‐Hui Zhang · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.